95 Views
Sunday Poster Session
Category: Liver
Daryl Ramai, MD, MSc
University of Utah
Salt Lake City, UT, United States
| GROUP 1 EUS-guided liver biopsy (54 pts) | GROUP 2 Percutaneous liver biopsy (62 pts) | p value |
Total length of specimen (mm) | | | 0.02 |
median (IQR) | 18.5 (10.1-22.4) | 27.4 (21-29) | |
No. of complete portal tracts | | | 0.09 |
Median (IQR) | 18.5 (10-23.2) | 21 (11-24) | |
Diagnostic adequacy | | | 0.74 |
| 51 (94.4%) | 62 (100%) | |
Diagnostic accuracy* | | | 0.82 |
| 24 (88.8%) | 31 (100%) | |
Final diagnosis | | | 0.74 |
Hepatocellular carcinoma Liver metastasis Chronic hepatitis NASH Normal liver | 12 14 17 4 7 | 16 10 24 4 8 | |
Procedural duration (mins) | | | < 0.001 |
median (min, max) | 7 (5- 11) | 1 (1-3) | |
Procedure-related adverse events | | | 1.0 |
| 0 (0%) | 0 (0%) | |
Values are expressed as number (percentage) or median (interquartile ranges) where specified. * Patients with focal lesions Abbreviations: EUS, Endoscopic Ultrasound; IQR, Interquartile Range |